Apimeds Pharmaceuticals US, Inc (AMEX: APUS) AI-Powered Stock Analysis
See how Apimeds Pharmaceuticals US, Inc scores across key metrics like financial growth, valuation, and market position on the AMEX, using AI-driven evaluation.
APUS●AMEX
HealthcareDrug Manufacturers - Specialty & Generic
$5.65
$0.88(13.52%)
U.S. Market opens in 65h 26m
Apimeds Pharmaceuticals US, Inc (AMEX: APUS) AI-Powered Stock Analysis
See how Apimeds Pharmaceuticals US, Inc scores across key metrics like financial growth, valuation, and market position on the AMEX, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerApimeds Pharmaceuticals US, Inc (AMEX: APUS) Stock Overall Grade
Apimeds Pharmaceuticals US, Inc's grade for its AMEX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Apimeds Pharmaceuticals US, Inc's overall AMEX stock rating.
Forecast
C+Score
53/100Financial Growth
CScore
40/100Fundamental Growth
DScore
30/100Key Ratios
C+Score
55/100Sector Comparison
AScore
80/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Apimeds Pharmaceuticals US, Inc (AMEX: APUS) AI-Powered Stock Analysis
On the AMEX, APUS demonstrates Normal performance with an overall Forecast Score of 53/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (30/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (80/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the AMEX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(AMEX: APUS) Component Analysis Explained
Understand the key factors behind each Apimeds Pharmaceuticals US, Inc (AMEX: APUS) stock grade, including financials, comparisons, and forecasts.